Laurus Labs

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE947Q01028
  • NSEID: LAURUSLABS
  • BSEID: 540222
INR
1,176.55
12.55 (1.08%)
BSENSE

May 06

BSE+NSE Vol: 43.37 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
1,811.57
1,778.29
1,653.47
1,569.57
1,720.30
1,415.05
1,223.70
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,811.57
1,778.29
1,653.47
1,569.57
1,720.30
1,415.05
1,223.70
Raw Material Cost
792.86
725.32
676.75
599.41
626.33
653.00
577.17
Purchase of Finished goods
48.24
55.12
30.70
38.50
22.31
34.79
25.59
(Increase) / Decrease In Stocks
-141.00
-85.87
-44.01
-0.56
134.04
-77.64
-54.46
Employee Cost
235.85
229.24
215.56
214.80
177.70
189.12
178.72
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
363.51
374.27
371.21
335.29
339.32
330.63
318.35
Total Expenditure (Excl Depreciation)
1,299.46
1,298.08
1,250.21
1,187.44
1,299.70
1,129.90
1,045.37
Operating Profit (PBDIT) excl Other Income
512.11
480.21
403.26
382.13
420.60
285.15
178.33
Other Income
11.80
5.76
26.96
10.43
58.57
9.42
4.60
Operating Profit (PBDIT)
523.91
485.97
430.22
392.56
479.17
294.57
182.93
Interest
40.44
38.79
40.00
51.50
56.40
57.80
52.61
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
483.47
447.18
390.22
341.06
422.77
236.77
130.32
Depreciation
122.10
120.62
120.49
116.84
110.43
106.09
107.51
Profit Before Tax
361.37
326.56
269.73
224.22
312.34
130.68
22.81
Tax
79.46
73.45
75.98
63.14
78.47
40.07
5.09
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
281.91
253.11
193.75
161.08
233.87
90.61
17.72
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
281.91
253.11
193.75
161.08
233.87
90.61
17.72
Share in Profit of Associates
0.18
-1.23
0.74
0.60
-1.10
2.33
2.23
Minority Interest
2.95
0.22
-0.48
-1.34
-0.90
0.64
0.11
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
279.14
251.66
194.97
163.02
233.67
92.30
19.84
Equity Capital
107.97
107.97
107.96
107.96
107.85
107.85
107.83
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
4,697.43
0.00
0.00
0.00
4,026.11
Earnings per share (EPS)
5.17
4.66
3.61
3.02
4.33
1.71
0.37
Diluted Earnings per share
5.17
4.65
3.61
3.02
4.33
1.71
0.37
Operating Profit Margin (Excl OI)
28.27%
27.0%
24.39%
24.35%
24.45%
20.15%
14.57%
Gross Profit Margin
26.69%
25.15%
23.6%
21.73%
24.58%
16.73%
10.65%
PAT Margin
15.56%
14.23%
11.72%
10.26%
13.59%
6.4%
1.45%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 5.31% vs 19.49% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 19.46% vs 209.05% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 21.76% vs 74.17% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is -28.30% vs 11.68% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Laurus Labs With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,811.57
3,736.82
-1,925.25
-51.52%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,811.57
3,736.82
-1,925.25
-51.52%
Raw Material Cost
792.86
937.77
-144.91
-15.45%
Purchase of Finished goods
48.24
327.96
-279.72
-85.29%
(Increase) / Decrease In Stocks
-141.00
6.98
-147.98
-2,120.06%
Employee Cost
235.85
721.51
-485.66
-67.31%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
363.51
914.60
-551.09
-60.25%
Total Expenditure (Excl Depreciation)
1,299.46
2,908.82
-1,609.36
-55.33%
Operating Profit (PBDIT) excl Other Income
512.11
828.00
-315.89
-38.15%
Other Income
11.80
143.10
-131.30
-91.75%
Operating Profit (PBDIT)
523.91
971.10
-447.19
-46.05%
Interest
40.44
42.10
-1.66
-3.94%
Exceptional Items
0.00
-52.79
52.79
100.00%
Gross Profit (PBDT)
483.47
876.21
-392.74
-44.82%
Depreciation
122.10
95.01
27.09
28.51%
Profit Before Tax
361.37
781.20
-419.83
-53.74%
Tax
79.46
127.67
-48.21
-37.76%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
281.91
653.53
-371.62
-56.86%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
281.91
653.53
-371.62
-56.86%
Share in Profit of Associates
0.18
-0.50
0.68
136.00%
Minority Interest
2.95
17.01
-14.06
-82.66%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
279.14
636.02
-356.88
-56.11%
Equity Capital
107.97
23.91
84.06
351.57%
Face Value
2.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
5.17
53.20
-48.03
-90.28%
Diluted Earnings per share
5.17
53.19
-48.02
-90.28%
Operating Profit Margin (Excl OI)
28.27%
22.16%
0.00
6.11%
Gross Profit Margin
26.69%
23.45%
0.00
3.24%
PAT Margin
15.56%
17.49%
0.00
-1.93%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,811.57 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 1.87% vs 7.55% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 5.31% vs 19.49% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 279.14 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 10.92% vs 29.08% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 19.46% vs 209.05% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 512.11 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 6.64% vs 19.08% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 21.76% vs 74.17% in Mar 2025

Quarterly - Interest
Interest 40.44 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 4.25% vs -3.03% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -28.30% vs 11.68% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.27%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025